Market Research

Technology Advancements to Conquer the Precision Medicine Market

January 18, 2018

SANTA CLARA, Calif., Jan. 17, 2018 /PRNewswire/ — Targeted and personalized therapeutics are likely to alter the existing precision medicine landscape. After the landmark US Food and Drug Administration (FDA) approval of Novartis’ CAR T-cell therapy, Kymriah, Frost & Sullivan finds that extensive work in CAR-T cells will fuel the development of transformative treatments. The […]

Thrombin Market to Reach US$690.1 Mn by 2025, Globally: Transparency Market Research

January 18, 2018

ALBANY, New York, January 18, 2018 /PRNewswire/ —   Global Thrombin Market: Rising Use of Thrombin for Various Diagnostics Procedures to Boost Growth   According to TMR, the global thrombin market is likely to reach US$690.1 mn by the end of 2025, as compared to US$496.1 mn in 2016. Between 2017 and 2025, the global […]

Active Pharmaceutical Ingredients (API) Market to Represent a Value of USD 239.8 Billion With CAGR Of 6.0% by 2025 | Million Insights

January 17, 2018

FELTON, California, January 17, 2018 /PRNewswire/ —   The global Active Pharmaceutical Ingredient (API) market size was worth at USD 134.2 billion in the year 2015 which is anticipated to reach a value of USD 239.8 billion by 2025, with CAGR of 6.0%. Rising prevalence of chronic diseases such as neurological diseases, cardiovascular diseases, can […]

Global Oligonucleotide Synthesis Market to Reach US$ 770 Mn by 2025 – Persistence Market Research

January 17, 2018

NEW YORK, January 17, 2018 /PRNewswire/ —   Oligonucleotides are short fragments of nucleic acids and play a major role in drug discovery and molecular diagnostic chip technology. Oligonucleotide synthesis occurs either commercially to provide services for various end users or individually via DNA synthesizers for self-consumption. The achievements of life sciences researchers and scientists […]

The Challenges and Opportunities of a Foreign Drug Registration in Russia, ARS PharmRussia Reveals

January 15, 2018

MOSCOW, Jan. 15, 2018 /PRNewswire/ — Few foreign biotechnology & pharmaceutical companies know about real chances to win state tenders in Russia. Overcoming local challenges, they gain great opportunities in drug development.   What an overseas maker needs to prepare   When applying for registration of medicines manufactured abroad, a potential marketing authorization holder (MAH) […]

Human Growth Hormone Market Worth $7.1 Billion by 2025 | CAGR: 7.5%: Grand View Research, Inc.

January 15, 2018

SAN FRANCISCO, January 15, 2018 /PRNewswire/ —   The global human growth hormone (hGH) market is expected to reach USD 7.1 billion by 2025, according to a new report by Grand View Research, Inc. Rising cases of pituitary dysfunction and increasing use of human growth hormone are likely to drive the market in coming years. […]

Novel Drug Delivery Systems in Cancer Therapy Market Worth $26.6 Billion by 2025: Grand View Research, Inc.

January 15, 2018

SAN FRANCISCO, January 15, 2018 /PRNewswire/ —   The global novel drug delivery systems (NDDS) in cancer therapy market is expected to reach USD 26.61 billion by 2025, according to a new report by Grand View Research, Inc. The market is primarily driven by global rise in incidence of cancer, increase in research activities for […]

Moxifloxacin Sales, Price Analysis, & Sales Forecasts 2010-2021 – Research and Markets

January 15, 2018

DUBLIN–(BUSINESS WIRE)–The “Moxifloxacin Sales, Price Analysis, & Sales Forecast – 2017” report has been added to ResearchAndMarkets.com’s offering.   “Moxifloxacin Sales, Price Analysis, & Sales Forecast – 2017” Tweet this Discover the growth trends of Moxifloxacin by countries, and also find out sales forecast until 2021. The research also provides Moxifloxacin unit price by countries. […]

Japanese pharma: No longer ‘lost in translation’

January 15, 2018

Amsterdam, 15th January 2018: A New Year report from CPhI forecasts 2018 will be a transformative year for Japanese pharma as the market evolves towards growth in generics, biosimilars and increased internationalisation. The CPhI Japan 2018 report – released ahead of what is likely to be the largest ever CPhI Japan (18-20 April, 2018) – has identified that demographic pressures […]

Pharmerging Market Size Worth $2,231.9 Billion by 2025, CAGR: 17.1%: Grand View Research, Inc.

January 11, 2018

SAN FRANCISCO, January 11, 2018 /PRNewswire/ —   The global pharmerging market is expected to reach USD 2,231.9 billion by 2025, according to a new report by Grand View Research, Inc. This market is expected to grow due to increasing geriatric population, increasing disease burden of chronic disorders and increasing healthcare expenditure.   (Logo: http://photos.prnewswire.com/prnh/20160524/371361LOGO […]

Drug Discovery IT Solutions to Hit $5.3 Billion Globally by 2020

January 10, 2018

SANTA CLARA, Calif., Jan. 10, 2018 /PRNewswire/ — The latest analysis, Growth Insights—Global Pharmaceutical Drug Discovery IT Solutions Market, Forecast to 2020, by Frost & Sullivan highlights the growing interest in big data analytics and artificial intelligence (AI)-based solutions. The study projects that market will reach $5.3 billion by 2020 at a compound annual growth […]

Use of Monoclonal Antibody Disease-Modifying Therapies on the Rise in Multiple Sclerosis, Fueled Largely by the Introduction of Genentech’s Ocrevus

January 10, 2018

EXTON, Pa., Jan. 10, 2018 /PRNewswire/ — With the April 2017 launch of Genentech’s Ocrevus, the monoclonal antibody (mAb) disease-modifying therapy (DMT) class share of DMT-treated multiple sclerosis (MS) patients has increased steadily over the past three consecutive quarters, according to neurologists’ self-reported prescribing behavior in the RealTime Dynamix™: Multiple Sclerosis (US) report series. Approximately […]

Heart Failure Drugs Market – 10.46% CAGR to 2022 | ReportsnReports

January 10, 2018

PUNE, India, January 10, 2018 /PRNewswire/ —   The Heart Failure Drugs Market analysis is provided for the international market including development history, competitive landscape analysis, and by major regions development status (Americas, APAC, EMEA) and other regions can be added development status. The analysts forecast global heart failure drugs market to grow at a […]

Anticancer Drugs Market to Reach US$155.6 Bn by 2025, Globally: Transparency Market Research

January 10, 2018

ALBANY, New York, January 10, 2018 /PRNewswire/ —   Global anticancer drugs market was valued at US$ 85.0 Bn in 2016 and is projected to expand at a CAGR of about 6 to 7% from 2017 to 2025 to reach US$ 155.6 Bn in 2025. This report offers a thorough understanding of anticancer drugs market […]

JAK Inhibitors Expected to Introduce Fierce Competition to Treatment Paradigms Across a Wide Range of Autoimmune Indications, Including Psoriatic Arthritis, Atopic Dermatitis, Ulcerative Colitis, and Lupus

January 10, 2018

EXTON, Pa., Jan. 10, 2018 /PRNewswire/ — On-going, independent research conducted by Spherix Global Insights over the past several years highlights expanding use of Pfizer’s JAK inhibitor Xeljanz (tofacitinib) in rheumatoid arthritis (RA), with momentum anticipated to continue. Over the past year, the Xeljanz user-base and rheumatologist reported satisfaction with the agent in RA has […]

Smart Pills Market Size Worth $3.0 Billion by 2025 | CAGR: 15.5%: Grand View Research, Inc.

January 10, 2018

SAN FRANCISCO, January 9, 2018 /PRNewswire/ —   The global smart pills market is expected to reach USD 3.0 billion by 2025 at a CAGR of 15.5% during the forecast period, according to a new report by Grand View Research, Inc. Increase in prevalence of diseases such as colorectal cancer and gastrointestinal disorders, expansion in […]

Global Pharmacovigilance Market Forecast 2018-2028

January 10, 2018

LONDON, January 9, 2018 /PRNewswire/ —   US, Japan, Germany, the UK, France, Italy, Spain, Brazil, Russia, India, China, South Korea, National Pharmacovigilance Systems, Leading Companies, Trends   The global pharmacovigilance market is expected to grow at a CAGR of 4.8% in the first half of the forecast period. The pharmacovigilance market is estimated to […]

Women’s Health Market is Expected to Rise at a CAGR of 5.7% During 2017 to 2025, Globally: Transparency Market Research

January 10, 2018

ALBANY, New York, January 10, 2018 /PRNewswire/ —   According to the report, the global women’s health market was valued at US$ 58.05 Bn in 2016 and is projected to expand at a CAGR of 5.7% from 2017 to 2025. This report offers an understanding of the global women’s health market, its key market trends, […]

Beta-glucan Market Size Worth $727.2 Million by 2025 | CAGR: 6.7%: Grand View Research, Inc.

January 9, 2018

SAN FRANCISCO, January 9, 2018 /PRNewswire/ —   The global beta-glucan market is expected to reach USD 727.2 million by 2025, according to a new report by Grand View Research, Inc. The industry is anticipated to grow, primarily on account of its increased application in industries, including nutraceutical, functional food and pharmaceutical.   (Logo: http://photos.prnewswire.com/prnh/20160524/371361LOGO […]

Bromelain Market Size Worth $59.2 Million by 2025 | Growth Rate: 8.7%: Grand View Research, Inc.

January 9, 2018

SAN FRANCISCO, January 9, 2018 /PRNewswire/ —   The global bromelain market is expected to reach USD 59.2 million by 2025, growing at a CAGR of 8.7%, according to a new report by Grand View Research, Inc. Rising expenditure in R&D to use bromelain to cure diseases such as cancer & acquired immune deficiency syndrome […]

Medication Management Market Size Worth $5.97 Billion By 2025: Grand View Research, Inc.

January 9, 2018

SAN FRANCISCO, January 9, 2018 /PRNewswire/ —   The global medication management system market is expected to reach USD 5.97 billion by 2025 at a CAGR of 20.5%, according to a new report by Grand View Research, Inc. Rise in number of prescriptions globally, increase in investments by hospitals for workflow management, advanced technologies, and […]

Nutraceuticals Market Size Worth $578.23 Billion by 2025 | CAGR: 8.8%: Grand View Research, Inc.

January 9, 2018

SAN FRANCISCO, January 9, 2018 /PRNewswire/ —   The global nutraceuticals market is projected to reach USD 578.23 billion by 2025, according to a new report by Grand View Research, Inc. Rising health concerns are likely to drive the product demand over the next eight years.   (Logo: http://photos.prnewswire.com/prnh/20160524/371361LOGO )   Growing awareness regarding the […]

Cell Line Development Market (2017-2022): Rapid Growth in Pharma Industry Key to Growth – Research and Markets

January 2, 2018

DUBLIN–(BUSINESS WIRE)–The “Cell Line Development Market: By Product, By Source, By Type, By Application, & By Region – Forecast (2017- 2022)” report has been added to Research and Markets’ offering.   “Cell Line Development Market: By Product, By Source, By Type, By Application, & By Region – Forecast (2017- 2022)” Tweet this Cell line construction […]

Frost & Sullivan Projects CRISPR Technology Will Be Fastest Growing Gene Editing Market Segment

December 22, 2017

SANTA CLARA, California, Dec. 22, 2017 /PRNewswire/ — Frost & Sullivan expects that multiple applications of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) genome editing technology can generate almost $25 billion in revenue by 2030s. Various CRISPR/Cas9 systems are being developed as new diagnostic tools and others are being programmed to edit DNA at precise […]

Amgen’s Erenumab is Poised to Become the First CGRP on the Market for Preventing Migraine says GlobalData

December 21, 2017

Biopharmaceutical company Amgen, has published the results from its Phase III trial STRIVE; which evaluated the efficacy of the drug erenumab – in the treatment of episodic migraine. It delivered significant differences versus the placebo in all endpoints, says GlobalData a leading data and analytics company. GlobalData healthcare analyst, Rahael Maladwala commented “A large proportion […]

Atorvastatin Market Top Manufacturers are Pfizer and Morepen | ReportsnReports

December 20, 2017

PUNE, India, December 20, 2017 /PRNewswire/ —   Atorvastatin market presents a detailed overview of the Atorvastatin Industry 2017 along with the key factors that are condemnatory in forming a holistic outline of the market, available at ReportsnReports.com.   Complete report on Atorvastatin market spread across 103 pages, profiling 08 companies and supported with 177 […]

Discontinuation of Sanofi’s C. difficile Vaccine Program presents an opportunity for Pfizer and Valneva, observes GlobalData

December 20, 2017

On December 1 2017, Sanofi Pasteur announced its intention to discontinue the Phase III development program for its Clostridium difficile vaccine. The vaccine was on track to become the first option available globally for the prevention of C. difficile, which GlobalData, a leading data and analytics company, estimated could reach peak annual sales of around […]

FEEDBACK